Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$0.58 - $17.99 $67 - $2,086
116 New
116 $0
Q1 2022

May 16, 2022

SELL
$1.63 - $2.55 $17,713 - $27,710
-10,867 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$2.27 - $3.0 $21,435 - $28,329
9,443 Added 663.13%
10,867 $26,000
Q3 2021

Nov 15, 2021

BUY
$2.45 - $4.1 $2,224 - $3,722
908 Added 175.97%
1,424 $5,000
Q2 2021

Sep 13, 2021

BUY
$3.0 - $4.39 $1,548 - $2,265
516 New
516 $2,000

Others Institutions Holding SYBX

About SYNLOGIC, INC.


  • Ticker SYBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,229,600
  • Market Cap $103M
  • Description
  • Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...
More about SYBX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.